CStone Pharmaceuticals Stock OTC Markets
Stocks
CSPHF
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
12:10:26 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.7547 USD | +11.10% |
|
+0.00% | -15.49% |
| 10-09 | GF Securities Starts CStone Pharmaceuticals at Buy with HK$11.56 Price Target | MT |
| 09-24 | CStone Pharma CEO Buys HK$2.7 Million of Shares | MT |
| Market Cap | 6.91B 1.03B 922M 857M 780M 1.48B 100B 1.48B 10.32B 4.04B 50.88B 3.89B 3.8B 164B | P/E 2026 * |
-15x | P/E 2027 * | 4.06x |
|---|---|---|---|---|---|
| Enterprise Value | 5.94B 888M 792M 736M 670M 1.27B 85.98B 1.27B 8.86B 3.47B 43.68B 3.34B 3.26B 141B | EV / Sales 2026 * |
14x | EV / Sales 2027 * | 1.68x |
| Free-Float |
79.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript: CStone Pharmaceuticals
| 1 day | +11.10% | ||
| 1 week | +0.00% | ||
| Current month | +0.00% | ||
| 1 month | -17.15% | ||
| 3 months | +26.95% | ||
| 6 months | -25.28% | ||
| Current year | -15.49% |
| 1 month | 0.66 |  | 0.75 |
| Current year | 0.59 | | 1.01 |
| 1 year | 0.59 | | 1.01 |
| 3 years | 0.11 | | 1.01 |
| 5 years | 0.11 | | 1.58 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 2022-08-24 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 2023-01-17 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 2016-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 2022-08-24 |
Edward Hu
BRD | Director/Board Member | 63 | 2021-07-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.10% | +0.00% | - | - | 1.06B | |
| +0.83% | +2.56% | +39.44% | +108.64% | 1,043B | |
| +1.93% | +1.07% | +37.82% | +65.85% | 618B | |
| +1.49% | +6.36% | +19.56% | +86.50% | 481B | |
| +2.26% | +1.24% | +68.52% | +40.16% | 351B | |
| +1.45% | +2.52% | +22.83% | +44.22% | 338B | |
| +1.17% | +0.88% | +11.83% | +34.76% | 269B | |
| +0.89% | -0.28% | -6.31% | +9.65% | 244B | |
| +1.82% | +1.87% | +40.82% | +55.11% | 220B | |
| +2.77% | +2.49% | +27.84% | +102.26% | 182B | |
| Average | +1.89% | +0.28% | +29.15% | +60.79% | 416.3B | |
| Weighted average by Cap. | +0.68% | +0.60% | +32.41% | +71.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 63.32M 56.41M 52.44M 47.73M 90.41M 6.13B 90.69M 631M 247M 3.11B 238M 233M 10.02B | 1.72B 258M 230M 213M 194M 368M 24.94B 369M 2.57B 1.01B 12.67B 968M 946M 40.78B |
| Net income | -384M -57.39M -51.13M -47.53M -43.26M -81.95M -5.55B -82.2M -572M -224M -2.82B -216M -211M -9.08B | 680M 102M 90.72M 84.32M 76.76M 145M 9.85B 146M 1.02B 397M 5.01B 382M 374M 16.11B |
| Net Debt | -978M -146M -130M -121M -110M -209M -14.16B -210M -1.46B -571M -7.19B -549M -537M -23.15B | -4.02B -602M -536M -498M -454M -859M -58.26B -862M -6B -2.35B -29.6B -2.26B -2.21B -95.25B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- CSPHF Stock
Select your edition
All financial news and data tailored to specific country editions
